$rgnx
$RGNX faces regulatory hurdles as FDA issues CRL for RGX-121, impacting its approval for MPS II. The company plans to resubmit the BLA, while discussions on social media highlight concerns about clinical trial data and FDA decision-making.
About $rgnx
$RGNX is a decentralized social media platform.
Insights
- $rgnx Creators hit a 52-Week high of [---] for the day
- $rgnx Creators hit an all time of [---] for the day
Engagements: [------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-----] -54%
[--] Month: [-------] +291%
[--] Months: [---------] -48%
[--] Year: [---------] +66%
1-Year High: [-------] on 2025-03-24
1-Year Low: [---] on 2025-08-24
Engagements by network (24h): X: [------] YouTube: [---]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [--]
1-Year High: [---] on 2025-11-26
1-Year Low: [--] on 2025-09-22
Mentions by network (24h): X: [---] YouTube: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $rgnx in the last [--] hours which is down 16% from [---] in the previous [--] hours
Daily Average: [--]
1-Year High: [---] on 2026-02-09
1-Year Low: [--] on 2025-09-19
The most influential creators that mention $rgnx in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @doepke_michel | [--] | [------] | [--] | [-----] |
| @surferbackpack | [--] | [---] | [--] | [-----] |
| @TraderNorway | [--] | [---] | [--] | [---] |
| @MarcJacksonLA | [--] | [-----] | [--] | [---] |
| @BuyTheUgly | [--] | [--] | [--] | [---] |
| @peter_mantas | [--] | [-----] | [--] | [---] |
| @BRSreality | [--] | [---] | [--] | [---] |
| @BiotechAutist | [--] | [-----] | [--] | [---] |
| @stevenplace | [--] | [-----] | [--] | [---] |
| @TTRAmyloid | [--] | [-----] | [--] | [--] |
Sentiment: 67%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 67%
Daily Average: 84%
[--] Week: 50% -30%
[--] Month: 61% -31%
[--] Months: 61% -39%
[--] Year: 61% -39%
1-Year High: 100% on 2025-02-15
1-Year Low: 20% on 2025-08-25
Most Supportive Themes:
- Community Focus: (45%) Posts highlight the platform's emphasis on building strong, user-driven communities.
- User Control: (35%) Content frequently discusses features that give users more control over their experience and data.
Most Critical Themes:
- Decentralization Challenges: (15%) Some discussions touch upon the technical hurdles and user adoption challenges of a decentralized model.
- Adoption Rate: (5%) Concerns are raised about the current pace of user acquisition and platform growth.
Top $rgnx Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"$SPRB adding on Monday. $IRON : PPIX had no validation as an endpoint. Weak correlation with clinical outcomes. Focused on reduction of PPIX. $RGNX : [--] year trial data Used HS-D2S6 (noisy). Focused on reduction. $SPRB : [--] year data HS-NRE Focused on Normalization"
X Link @surferbackpack 2026-02-14T03:30Z [---] followers, [----] engagements
"So $SPRB got smoked 20% on news of a CRL for $IRON Between $RGNX and $IRON CRLs the risk has clearly risen"
X Link @jacobg0121 2026-02-13T22:02Z [---] followers, [----] engagements
"Wow. CDER published the $DISC CRL the day it was issued. Meanwhile CBER still hasn't released the $ATRA and $RGNX CRLs. https://download.open.fda.gov/crl/CRL_NDA220707_20260213.pdf https://download.open.fda.gov/crl/CRL_NDA220707_20260213.pdf"
X Link @TwongStocks 2026-02-13T20:53Z [---] followers, [---] engagements
"@adamfeuerstein @LizzyLaw_ Its becoming a circus over there. The $RGNX and $ATRA declines were more understandable than $IRON"
X Link @BehavioralAdvan 2026-02-13T20:39Z [---] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing